A coronal virus vaccine invention patent completed by Chen Wei, a member of the Chinese Academy of Engineering and a researcher at the Academy of Military Medical Sciences, won the Chinese Patent Gold Award.
According to the WeChat public account of the "Academy of Military Sciences", the results of the 23rd China Patent Award review results were revealed on Tuesday (July 26), and the "one kind of people copy the defect adenovirus virus by the person who led by Chen WeiThe invention patent for the reorganization of the new type of coronary virus vaccine for the carrier won the Chinese patent gold award.
It is reported that this patent is the first Chinese patent gold award since the establishment of the newly adjusted Chinese Academy of Military Sciences.Outstanding results achieved during the creation, protection and application of self -intellectual property rights.
It is understood that the invention was awarded the invention patent right by the China State Intellectual Property Office in August 2020 (patent number 202010193587.8).This invention has a good immune protection effect on the coronary virus, and is prepared quickly and simple, which can achieve large -scale production in the short term.
The report also stated that the Chinese Patent Award is the highest -level government award of the invention of patent rights by the Chinese government, which has been recognized by the United Nations World Intellectual Property Organization and has a strong social influence and authority.
This award mainly focuses on the core technologies of key industries and key areas, highlight the "big country's heavy weapon" of the manufacturing industry, solve the technical problem of "stuck neck", and reflects the industry's highest technology level.This year's Chinese Patent Award has selected a total of 30 Chinese Patent Gold Awards, 60 Silver Awards, and 792 Excellent Awards.
